| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |